BRPI0816992A2 - Derivado heterocíclico tricícloco, e, composição farmacêutica - Google Patents

Derivado heterocíclico tricícloco, e, composição farmacêutica

Info

Publication number: BRPI0816992A2
Authority: BR; Brazil
Prior art keywords: pharmaceutical composition; heterocyclic derivative; tricyclic heterocyclic; tricyclic; derivative
Prior art date: 2007-09-17

Application number

Other languages

English (en)

Inventor

Simon James Anthony Grove

Takao Kiyoi

Ashvinkumar Dhirubhai Mistry

Peter Christopher Ray

Grant Wishart

Original Assignee

Organon Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-09-17

Filing date

2008-09-15

Publication date

2015-03-24

2008-09-15 Application filed by Organon Nv filed Critical Organon Nv

2015-03-24 Publication of BRPI0816992A2 publication Critical patent/BRPI0816992A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Anesthesiology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

BRPI0816992 2007-09-17 2008-09-15 Derivado heterocíclico tricícloco, e, composição farmacêutica BRPI0816992A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07116561		2007-09-17
PCT/EP2008/062229 WO2009037220A1 (en)	2007-09-17	2008-09-15	Tricyclic heterocyclic derivatives

Publications (1)

Publication Number	Publication Date
BRPI0816992A2 true BRPI0816992A2 (pt)	2015-03-24

Family

ID=39718515

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0816992 BRPI0816992A2 (pt)	2007-09-17	2008-09-15	Derivado heterocíclico tricícloco, e, composição farmacêutica

Country Status (17)

Country	Link
US (1)	US20100210680A1 (pt)
EP (1)	EP2203454A1 (pt)
JP (1)	JP5447380B2 (pt)
KR (1)	KR20100072027A (pt)
CN (1)	CN101801980B (pt)
AR (1)	AR068521A1 (pt)
AU (1)	AU2008300607B2 (pt)
BR (1)	BRPI0816992A2 (pt)
CA (1)	CA2698436A1 (pt)
CL (1)	CL2008002767A1 (pt)
CO (1)	CO6260138A2 (pt)
MX (1)	MX2010002900A (pt)
NZ (1)	NZ583627A (pt)
PE (1)	PE20090704A1 (pt)
RU (1)	RU2010115337A (pt)
TW (1)	TW200924752A (pt)
WO (1)	WO2009037220A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8518933B2 (en)	2009-04-23	2013-08-27	Abbvie Inc.	Modulators of 5-HT receptors and methods of use thereof
US8546377B2 (en)	2009-04-23	2013-10-01	Abbvie Inc.	Modulators of 5-HT receptors and methods of use thereof
RU2542103C2 (ru)	2009-05-22	2015-02-20	Эббви Инк.	Модуляторы рецепторов 5-нт и способы их применения
WO2011146089A1 (en)	2010-05-21	2011-11-24	Abbott Laboratories	Modulators of 5-ht receptors and methods of use thereof
US20130267500A1 (en)	2010-09-01	2013-10-10	Arena Pharmaceuticals, Inc.	5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level
US20120309796A1 (en)	2011-06-06	2012-12-06	Fariborz Firooznia	Benzocycloheptene acetic acids
WO2015066344A1 (en)	2013-11-01	2015-05-07	Arena Pharmaceuticals, Inc.	5-ht2c receptor agonists and compositions and methods of use
EP3762379A1 (en)	2018-03-07	2021-01-13	Bayer Aktiengesellschaft	Identification and use of erk5 inhibitors
WO2024091983A1 (en) *	2022-10-25	2024-05-02	Artus Therapeutics, Inc.	Therapeutic agents for enhancing epithelial and/or endothelial barrier function
CN116253627B (zh) *	2022-12-27	2025-09-05	大连双硼医药化工有限公司	一种合成2-溴-6-羟基苯甲醛的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4132709A (en) *	1976-12-20	1979-01-02	Ayerst, Mckenna & Harrison, Ltd.	[2]Benzopyrano[4,3-c]pyridine derivatives and process therefor
US4132710A (en)	1976-12-20	1979-01-02	Ayerst, Mckenna And Harrison, Ltd.	[2]Benzopyrano[3,4-c]pyridines and process therefor
NL8005754A (nl) *	1980-10-18	1982-05-17	Akzo Nv	Benzo 4,5 pyrano 2,3-c pyrrool derivaten.
US4666916A (en)	1985-11-08	1987-05-19	Ciba-Geigy Corporation	Hexahydro-(1)-benzo-(pyrano and thiopyrano) (4,3-C)pyridines, useful as serotin-2 blocking agents
ATE139230T1 (de) *	1988-12-15	1996-06-15	Abbott Lab	5-ht-selektive mittel
US5049564A (en) *	1989-11-17	1991-09-17	Abbott Laboratories	5-HT selective agents
GB8917333D0 (en) *	1989-07-28	1989-09-13	Merck Sharp & Dohme	Therapeutic agents
AU2559392A (en) *	1991-10-24	1993-05-21	Upjohn Company, The	Benzo-isoquinoline derivatives and analogs and their use in therapeutics
FR2722194B1 (fr)	1994-07-06	1996-08-23	Adir	Nouveaux derives de benzopyrane, leur procede de preparation et les compositions pharmacuetiques qui les contiennent

2008
- 2008-09-10 TW TW097134706A patent/TW200924752A/zh unknown
- 2008-09-15 EP EP08804190A patent/EP2203454A1/en not_active Withdrawn
- 2008-09-15 US US12/678,184 patent/US20100210680A1/en not_active Abandoned
- 2008-09-15 RU RU2010115337/04A patent/RU2010115337A/ru unknown
- 2008-09-15 WO PCT/EP2008/062229 patent/WO2009037220A1/en not_active Ceased
- 2008-09-15 BR BRPI0816992 patent/BRPI0816992A2/pt not_active Application Discontinuation
- 2008-09-15 NZ NZ583627A patent/NZ583627A/en not_active IP Right Cessation
- 2008-09-15 CN CN200880107460.7A patent/CN101801980B/zh not_active Expired - Fee Related
- 2008-09-15 AU AU2008300607A patent/AU2008300607B2/en not_active Ceased
- 2008-09-15 JP JP2010524519A patent/JP5447380B2/ja not_active Expired - Fee Related
- 2008-09-15 KR KR1020107008334A patent/KR20100072027A/ko not_active Withdrawn
- 2008-09-15 MX MX2010002900A patent/MX2010002900A/es not_active Application Discontinuation
- 2008-09-15 CA CA2698436A patent/CA2698436A1/en not_active Abandoned
- 2008-09-16 PE PE2008001616A patent/PE20090704A1/es not_active Application Discontinuation
- 2008-09-16 AR ARP080104015A patent/AR068521A1/es unknown
- 2008-09-16 CL CL2008002767A patent/CL2008002767A1/es unknown
2010
- 2010-03-17 CO CO10031803A patent/CO6260138A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
RU2010115337A (ru)	2011-10-27
PE20090704A1 (es)	2009-06-20
MX2010002900A (es)	2010-03-31
US20100210680A1 (en)	2010-08-19
CO6260138A2 (es)	2011-03-22
CL2008002767A1 (es)	2009-03-06
AU2008300607B2 (en)	2013-08-22
AU2008300607A1 (en)	2009-03-26
CA2698436A1 (en)	2009-03-26
TW200924752A (en)	2009-06-16
WO2009037220A1 (en)	2009-03-26
EP2203454A1 (en)	2010-07-07
NZ583627A (en)	2011-08-26
CN101801980A (zh)	2010-08-11
JP2010539139A (ja)	2010-12-16
JP5447380B2 (ja)	2014-03-19
AR068521A1 (es)	2009-11-18
KR20100072027A (ko)	2010-06-29
CN101801980B (zh)	2014-03-12

Publication	Publication Date	Title
LTPA2018005I1 (lt)	2018-02-12	Farmacinė kompozicija
DK2207773T3 (da)	2012-09-10	Heterocyklisk forbindelse og farmaceutisk sammensætning deraf.
BRPI0721651A2 (pt)	2014-04-01	Composição farmacêutica
BRPI0906962A2 (pt)	2015-07-14	Composto, e, composição farmacêutica
BRPI0906556A2 (pt)	2015-07-07	Composto, e, composição farmacêutica
BRPI0715712A2 (pt)	2014-06-24	Composição farmacêutica
BRPI0719393A2 (pt)	2015-03-31	Composição farmacêutica
DK2164844T3 (da)	2012-08-20	Pyrimidinyl-pyridazinonderivater
DK2209786T3 (da)	2013-06-03	Pyrimidinsubstituerede purinderivater
BRPI1013642A2 (pt)	2016-04-19	derivado de triazina e composição farmacêutica compreendendo o mesmo
BRPI0816992A2 (pt)	2015-03-24	Derivado heterocíclico tricícloco, e, composição farmacêutica
DK2120884T3 (da)	2011-02-07	Farmaceutisk sammensætning
DK2254873T3 (da)	2014-06-30	Benzodiazepinforbindelse og farmaceutisk sammensætning.
BRPI0809346A2 (pt)	2014-10-07	Compostos derivados substituídos de imidazopiridina e composição farmacêutica contendo os mesmos
BRPI0813836A2 (pt)	2015-01-06	Derivados pirazólicos
BRPI0917681A2 (pt)	2015-08-04	Composto, e, composição farmacêutica
DK3492069T3 (da)	2022-03-14	Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
DK1940467T3 (da)	2017-02-13	Lægemiddelsammensætning med langvarig frigivelse
ATE518837T1 (de)	2011-08-15	Indazolamidderivate
BRPI0905369A2 (pt)	2015-06-30	Composição farmacêutica, composição e kit compartimentado
BRPI0716445A2 (pt)	2013-09-17	composiÇço farmacÊutica
BRPI0720234A2 (pt)	2013-12-24	Composição farmacêutica
DK2152370T3 (da)	2011-08-15	Aryletherpyridazinonderivater
BRPI0807078A2 (pt)	2014-04-08	Composto, e, formulação farmacêutica
PT2209464E (pt)	2014-09-05	Composição farmacêutica antimalárica

Legal Events

Date	Code	Title	Description
2015-06-09	B11A	Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
2015-09-08	B11Y	Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]